Sign in
4

Changes in Ownership

ADMA BIOLOGICS, INC. Filed Acc 0001140361-25-035159

President and CEO sold 21,000 shares at $16.13 ($338,730)

  • President and CEO acquired 15,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Grossman Adam S President and CEO 2025-09-15 Option exercise 10b5-1 +15,000 $5.40 $81,000 2,046,850 D
Grossman Adam S President and CEO 2025-09-15 Sale 10b5-1 −15,000 $16.13 $241,950 2,031,850 D
Grossman Adam S President and CEO 2025-09-15 Sale 10b5-1 −6,000 $16.13 $96,780 2,025,850 D
Derivatives
Grossman Adam S President and CEO 2025-09-15 Option exercise · Stock Option (right to buy) 10b5-1 −15,000 765,950 D
Open-market sales · 21,000 sh · avg $16.13 · $338,730
Loading xslF345X05/form4.xml…